GlaxoSmithKline PLC Director/PDMR Shareholding (3167T)
24 November 2021 - 2:06AM
UK Regulatory
TIDMGSK
RNS Number : 3167T
GlaxoSmithKline PLC
23 November 2021
GlaxoSmithKline plc (the ' Company ')
Transaction notification
1. Details of PDMR/person closely associated with them
('PCA')
==== ===========================================================================================
a) Name Dr H Barron
==== ======================================== =================================================
b) Position/status Chief Scientific Officer and President,
R&D
==== ======================================== =================================================
c) Initial notification/ Initial notification
amendment
==== ======================================== =================================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
==== ===========================================================================================
a) Name GlaxoSmithKline plc
==== ======================================== =================================================
b) LEI 5493000HZTVUYLO1D793
==== ======================================== =================================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
==== ===========================================================================================
a) Description of American Depositary Shares ('ADSs')
the financial
instrument ISIN: US37733W1053
==== ======================================== =================================================
b) Nature of the Acquisition of notional ADSs within Dr
transaction Barron's GSK Executive Supplemental Savings
Plan account following the reinvestment
of dividends
==== ======================================== =================================================
c) Price(s) and Price(s) Volume(s)
volume(s)
==== ======================================== ===================== =======================
$41.5000 2,626.374
===================== =======================
d) Aggregated information N/A (single transaction)
====
Aggregated volume
Price
========================================= =====================================================
e) Date of the transaction 2021-11-18
==== ======================================== =================================================
f) Place of the New York Stock Exchange (XNYS)
transaction
==== ======================================== =================================================
1. Details of PDMR/person closely associated with them
('PCA')
==== ==================================================================================================
a) Name Dr H Barron
==== ======================================== ========================================================
b) Position/status Chief Scientific Officer and President,
R&D
==== ======================================== ========================================================
c) Initial notification/ Initial notification
amendment
==== ======================================== ========================================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
==== ==================================================================================================
a) Name GlaxoSmithKline plc
==== ======================================== ========================================================
b) LEI 5493000HZTVUYLO1D793
==== ======================================== ========================================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
==== ==================================================================================================
a) Description of American Depositary Shares ('ADSs')
the financial
instrument ISIN: US37733W1053
==== ======================================== ========================================================
b) Nature of the Acquisition of ADSs within Dr Barron's
transaction GSK 401(k) plan account following the reinvestment
of dividends
==== ======================================== ========================================================
c) Price(s) and Price(s) Volume(s)
volume(s)
==== ======================================== ======================== ===========================
$41.5000 65
======================== ===========================
d) Aggregated information N/A (single transaction)
====
Aggregated volume
Price
========================================= ============================================================
e) Date of the transaction 2021-11-18
==== ======================================== ========================================================
f) Place of the New York Stock Exchange (XNYS)
transaction
==== ======================================== ========================================================
1. Details of PDMR/person closely associated with them
('PCA')
==== =========================================================================================
a) Name Mr J Ford
==== ======================================== ===============================================
b) Position/status SVP & General Counsel
==== ======================================== ===============================================
c) Initial notification/ Initial notification
amendment
==== ======================================== ===============================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
==== =========================================================================================
a) Name GlaxoSmithKline plc
==== ======================================== ===============================================
b) LEI 5493000HZTVUYLO1D793
==== ======================================== ===============================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
==== =========================================================================================
a) Description of American Depositary Shares ('ADSs')
the financial
instrument ISIN: US37733W1053
==== ======================================== ===============================================
b) Nature of the Acquisition of notional ADSs within Mr
transaction Ford's GSK Executive Supplemental Savings
Plan account following the reinvestment
of dividends
==== ======================================== ===============================================
c) Price(s) and Price(s) Volume(s)
volume(s)
==== ======================================== ==================== ======================
$41.5000 62.798
==================== ======================
d) Aggregated information N/A (single transaction)
====
Aggregated volume
Price
========================================= ===================================================
e) Date of the transaction 2021-11-18
==== ======================================== ===============================================
f) Place of the New York Stock Exchange (XNYS)
transaction
==== ======================================== ===============================================
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
DSHEXLFLFFLBFBE
(END) Dow Jones Newswires
November 23, 2021 10:06 ET (15:06 GMT)
Gsk (LSE:GSK)
Historical Stock Chart
From Dec 2024 to Jan 2025
Gsk (LSE:GSK)
Historical Stock Chart
From Jan 2024 to Jan 2025
